Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig
- Address
- lock Available on a paid plan
Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig
This medical practice specializes in gastrointestinal research with particular expertise in functional bowel disorders. The center conducts clinical investigations focused on evidence-based treatments for chronic digestive conditions affecting quality of life.
- Irritable Bowel Syndrome with diarrhea-predominant subtype (IBS-D)
- Probiotic and microbiome-based therapeutic interventions
- Symptom management and patient-reported outcomes in functional gastrointestinal disorders
The practice demonstrates commitment to rigorous clinical trial methodology, including randomized, double-blind, placebo-controlled studies evaluating novel treatments. Their research portfolio includes investigations of living bacterial therapeutics and their role in modulating gastrointestinal function, with comprehensive assessment of efficacy, safety, and tolerability profiles in patient populations with chronic digestive disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Amgen Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Metsera Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gemeinschaftspraxis Dres. Holger Kittner und Kerstin Hartig
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Cannabis Sativa Flower Aerosol via Syqe Inhaler in Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial | Syqe Medical Ltd. | Phase II | Not Recruiting | Nov 2024 | Jun 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cannabis Sativa Flower | 1 | Unknown | 2024-11-14 | 2024-11-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.